Homozygosity Mapping of a Gene Responsible for Gelatinous Drop–like Corneal Dystrophy to Chromosome 1p  by Tsujikawa, Motokazu et al.
Am. J. Hum. Genet. 63:1073–1077, 1998
1073
Homozygosity Mapping of a Gene Responsible for Gelatinous Drop–like
Corneal Dystrophy to Chromosome 1p
Motokazu Tsujikawa,1,2 Hiroki Kurahashi,1 Toshihiro Tanaka,3 Masaki Okada,2
Syuji Yamamoto,2 Naoyuki Maeda,2 Hitoshi Watanabe,2 Yoshitsugu Inoue,2
Akira Kiridoshi,2 Kouki Matsumoto,4 Yuichi Ohashi,5 Shigeru Kinoshita,6
Yoshikazu Shimomura,2 Yusuke Nakamura,1,3 and Yasuo Tano2
1Division of Clinical Genetics, Department of Medical Genetics, Biomedical Research Center, and 2Department of Ophthalmology, Osaka
University Medical School, Osaka; 3Human Genome Center, Laboratory of Molecular Medicine, Institute of Medical Science, University of
Tokyo, Tokyo; 4Department of Ophthalmology, Kumamoto University School of Medicine, Kumamoto, Japan; 5Department of Ophthalmology,
Ehime University School of Medicine, Ehime, Japan; and 6Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto
Summary
Gelatinous drop–like corneal dystrophy (GDLD) is a
rare autosomal recessive disorder characterized clinically
by grayish corneal deposits of amyloid and by severely
impaired visual acuity. Most patients require corneal
transplantation. To localize a gene responsible for
GDLD, we performed linkage analysis of 10 consan-
guineous Japanese families with a total of 13 affected
members. Homozygosity mapping provided a maximum
LOD score of 9.80 at the D1S2741 marker locus on the
short arm of chromosome 1. Haplotype analysis further
defined the disease locus within a region of ∼2.6 cM
between D1S2890 and D1S2801.
Introduction
Gelatinous drop–like corneal dystrophy (GDLD; MIM
204870) is a rare autosomal recessive disease. It is char-
acterized by the deposition of amyloid material in the
subepithelial space of the cornea and was first reported
by Nakaizumi (1914). Clinical manifestations appear in
the 1st decade of life and include blurred vision, pho-
tophobia, and foreign-body sensation. Later, raised, yel-
lowish-gray gelatinous masses severely impair visual
acuity, and lamellar keratoplasty is required for most
patients (Smolin 1994). Unfortunately, the same con-
dition often develops in the transplanted cornea within
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several years, and additional keratoplasty is needed. The
incidence of this disease is estimated to be ∼1/300,000
in Japan, whereas only a few cases have been reported
in Western countries (Ramsey et al. 1972; Weber and
Babel 1980).
In recent years, positional-cloning approaches have
led to the discovery of a large number of genes respon-
sible for hereditary disorders. Although mutant genes
responsible for some corneal dystrophies have been iden-
tified, the molecular basis of GDLD remains unknown.
In an effort to localize a GDLD gene, we undertook a
genomewide scan, using microsatellite markers to detect
regions showing frequent homozygosity among 13 af-
fected offspring of 10 consanguineous Japanese mar-
riages. In this way, we mapped the disease locus to the
short arm of chromosome 1.
Patients and Methods
Patients
The pedigree structures of the Japanese families par-
ticipating in this study are shown in figure 1. The parents
in each family are first cousins. All participating family
members were examined and diagnosed by slit-lamp
biomicroscopy. Individuals whose corneal surface had a
mulberry appearance (fig. 2) were diagnosed as affected.
From each participant, 20 ml of peripheral blood was
drawn, with informed consent. Genomic DNA was ex-
tracted from white cells by standard methods (Grimberg
et al. 1989).
Genotyping
A genomewide scan was performed with 63 fluores-
cently labeled microsatellite markers (Linkage Mapping
Set; Perkin-Elmer) distributed at intervals of ∼10 cM
(Weissenbach et al. 1992; Gyapay et al. 1994). Each PCR
was carried out in a 15-ml reaction mixture containing
20 ng of genomic DNA, 20 pmol of each primer, 1.0–2.5
Figure 1 Pedigree and haplotype data for 10 GDLD families. All parents in these marriages are first cousins. Genotypes unavailable
because of lack of DNA are denoted by dashes (–). The homozygous region of each affected individual is boxed.
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Figure 2 Phenotype of GDLD. The corneal surface has a mulberry appearance.
mM MgCl2, 1# reaction buffer (Takara), 200 mM of
each dNTP, and 1.0 unit of EXTaq polymerase (Takara).
Samples were amplified in 35 cycles of 20 s at 94C, for
denaturing, 20 s at optimum annealing temperature, and
20 s at 72C for extension, in a GeneAmp 9600 ther-
mocycler (Perkin-Elmer). Alleles were separated by elec-
trophoresis on a 4% denaturing polyacrylamide gel for
2 h in a model 377 DNA sequencer (Perkin-Elmer).
Genescan analysis software was used to determine allele
sizes.
We selected seven additional markers on chromo-
some 1p (D1S2890, D1S2650, D1S2869, D1S2831,
D1S2741, D1S2801, and D1S2873) for fine mapping
(Gyapay et al. 1994). For genotyping, one of the PCR
primers for each marker was end-labeled with g[32P]-
ATP by T4 polynucleotide kinase. PCR conditions were
the same as those used for the fluorescently labeled
markers. Alleles were separated on 6% denaturing poly-
acrylamide gels at 1,700–2,200 V for 3–5 h and were
visualized by exposure to x-ray film for 5–12 h.
Linkage analysis
Linkage analysis was performed with FASTLINK soft-
ware, version 4.0P (Lathrop et al. 1984; Cottingham et
al. 1993), under the assumption of autosomal recessive
inheritance with complete penetrance and a gene fre-
quency of .001, on the basis of allele frequencies in x64
chromosomes from unrelated healthy Japanese. Recom-
bination frequencies were assumed to be equal in males
and females.
Linkage-Disequilibrium Analysis
For each consanguineous family, a disease chromo-
some was identified and used for linkage-disequilibrium
analysis, except for the five loci D1S197, D1S2890,
D1S2801, D1S2873, and D1S216, since we were unable
to define the disease-carrying chromosome. An assess-
ment of allelic association was performed by comparison
of allele frequencies in the GDLD chromosome versus
those in x64 chromosomes from unrelated healthy Jap-
anese. The table x2 test was performed.2# n
Results
After examining 63 markers distributed throughout
the genome, we found that all 13 affected members and
none of the 11 unaffected members of the 10 consan-
guineous GDLD families studied were homozygous at
the D1S220 locus on the short arm of chromosome 1.
Using additional markers flanking the D1S220 locus to
confirm the evidence of linkage, we found that all of the
affected individuals were homozygous for two addi-
tional markers (D1S2831 and D1S2741) on the proxi-
mal side of D1S220 and also for two markers on the
distal side (D1S2869 and D1S2650; see fig. 1). Table 1
summarizes the results of pairwise linkage analysis at
each of 10 marker loci on chromosome 1p. Five markers
revealed no recombination, with LOD scores of 4.40–
9.80; the maximum score of 9.80 was obtained at the
D1S2741 locus. Haplotype analysis (see fig. 1) indicated
that two patients from family 4 and one patient from
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Table 1
Pairwise LOD Scores at 10 Loci on Chromosome 1p
LOCUS
LOD SCORE AT RECOMBINATION FRACTION OF
MAXIMUM
LOD SCORE
MAXIMUM
RECOMBINATION
FRACTION.00 .01 .05 .10 .20 .30 .40
D1S197 1.65 3.62 4.58 4.31 3.07 1.78 .72 4.58 .05
D1S2890 .16 1.62 2.26 2.10 1.40 .73 .25 2.26 .06
D1S2650 4.40 4.26 3.71 3.08 1.99 1.13 .48 4.40 .00
D1S2869 5.67 5.48 4.73 3.85 2.34 1.22 .45 5.67 .00
D1S220 8.36 8.11 7.13 5.95 3.77 2.01 .77 8.36 .00
D1S2831 8.88 8.66 7.76 6.55 4.57 2.73 1.20 8.88 .00
D1S2741 9.80 9.75 8.62 7.44 5.16 3.09 1.35 9.80 .00
D1S2801  4.67 5.14 4.67 3.29 1.96 .86 5.17 .04
D1S2873  5.48 5.94 5.45 3.96 2.43 1.10 5.97 .04
D1S216  8.27 3.06 1.21 .06 .15 .09 .15 .31
Table 2
Linkage-Disequilibrium Analysis
LOCUS x2 P
D1S2650 3.32 .35
D1S2869 7.64 .37
D1S220 36.24 !.001
D1S2831 13.87 .18
D1S2741 17.42 .026
family 5 were heterozygous at the D1S2890 locus prox-
imal to D1S220 and that one patient from family 2 and
one patient from family 9 were heterozygous at the
D1S2801 locus distal to D1S220. These cases defined
the critical region for GDLD, within a 2.6-cM interval
between D1S2890 and D1S2801. Furthermore, we
found that 8 (80%) of 10 disease chromosomes carried
the 247-bp allele at the D1S220 marker locus, whereas
only 5% of the control chromosome carried this allele.
As summarized in table 2, a significant linkage disequi-
librium between GDLD and the locus D1S220 ( 2x 
; ) was observed, indicating that the36.24 P ! .001
GDLD locus and the D1S220 locus are in very close
proximity.
Discussion
Homozygosity mapping has proved to be a powerful
method for the mapping of autosomal recessive diseases.
One advantage of this strategy is that it requires only a
small number of patients from consanguineous mar-
riages. The very low incidence of GDLD makes it dif-
ficult to define the disease locus by means of linkage
analysis in nonconsanguineous families. Using DNA
from only 13 affected individuals among 10 consan-
guineous Japanese families, we successfully assigned the
gene for GDLD to the D1S220 locus on the short arm
of chromosome 1. Subsequent linkage and haplotype
analyses with D1S220 and nine other microsatellite
markers revealed that all 13 affected individuals were
homozygous at four other marker loci: D1S2650,
D1S2869, D1S2831, and D1S2741. This result localized
the GDLD locus within a 2.6-cM interval between
D1S2890 and D1S2801.
The serum amyloid P gene (SAP; Whitehead et al.
1988) and the transforming growth factor b–induced
gene (big-h3; Skonier et al. 1992) have been considered
as candidate genes for GDLD. Although the amyloid
deposit observed in the corneas of GDLD patients is of
the SAP type (Mondino et al. 1981), the SAP gene is
located on chromosome 1q12-q23; hence, our results
excluded mutation of the SAP gene as the cause of
GDLD in our panel of families. Similarly, big-h3, which
is responsible for lattice corneal dystrophy type I, an-
other form of corneal amyloidosis (Munier et al. 1997),
was also excluded as a candidate, because it lies on chro-
mosome 5q31. We also excluded the 16q22 region,
where the gene for macular corneal dystrophy has been
mapped (Vance et al. 1996).
To our knowledge, only two genes, one encoding a
serine-threonine kinase (Hanes et al. 1994) and the other
an AMP-activated protein kinase (Beri et al. 1994), have
been assigned to the interval between D1S2890 and
D1S2801. Since the biological functions of these two
enzymes are not known in detail, each could be a can-
didate for GDLD. The incidence of this disease is much
higher in Japan and only a few cases of GDLD have
been reported in other countries. This fact anticipates a
founder mutation in strong linkage disequilibrium with
close markers of the disease gene. In fact, our linkage-
disequilibrium analysis has disclosed significant linkage
disequilibrium between D1S220 and GDLD, indicating
that the GDLD locus and the D1S220 locus are in very
close proximity.
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